Last checked at 
Tern PLC - internet of things-focused investor - Portfolio company FVRVS Ltd wins GBP400,000 contract with existing client, a "leading pharmaceutical" firm, to support training and adoption of Ocular Gene Therapy product. "The contract covers ongoing repeat licences and support to continue the global rollout of the client's virtual reality training solution, built by FundamentalVR," Tern says.
Current stock price: 6.88 pence
Year-to-date change: down 21%
By Eric Cunha; ericcunha@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.